FXR1 is one of the two known homologues of FMR1. FXR1 shares a high degree of sequence homology with FMR1 and also encodes two KH domains and an RGG domain, conferring RNA-binding capabilities. In comparison with FMRP, very little is known about the function of FXR1P in vivo. Mouse knockout (KO) models exist for both Fmr1 and Fxr2. To study the function of Fxr1 in vivo, we generated an Fxr1 KO mouse model. Homozygous Fxr1 KO neonates die shortly after birth most likely due to cardiac or respiratory failure. Histochemical analyses carried out on both skeletal and cardiac muscles show a disruption of cellular architecture and structure in E19 Fxr1 neonates compared with wild-type (WT) littermates. In WT E19 skeletal and cardiac muscles, Fxr1p is localized to the costameric regions within the muscles. In E19 Fxr1 KO littermates, in addition to the absence of Fxr1p, costameric proteins vinculin, dystrophin and a-actinin were found to be delocalized. A second mouse model (Fxr1 1 neo) , which expresses strongly reduced levels of Fxr1p relative to WT littermates, does not display the neonatal lethal phenotype seen in the Fxr1 KOs but does display a strongly reduced limb musculature and has a reduced life span of 18 weeks. The results presented here point towards a role for Fxr1p in muscle mRNA transport/translation control similar to that seen for Fmrp in neuronal cells.
INTRODUCTION
FXR1 and FXR2 are the two known vertebrate autosomal homologues of the X-linked FMR1 gene (1, 2) . Mutations in the FMR1 gene cause the most common hereditary form of mental retardation in humans, the fragile X syndrome (3) (reviewed in 4). FXR1 was isolated initially from a Xenopus laevis cDNA library and found to share 60% identity at the amino acid level with the protein encoded for by FMR1, FMRP (1) . Members of the FMR1 gene family exhibit two highly conserved KH domains and an RGG region that are found in many RNA-binding proteins. FMR1P and its homologues have been found to bind a variety of RNAs (5, 6) . Given the high degree of protein similarity among members of the FMR1 gene family, it is possible that these genes have overlapping functions. In fragile X syndrome, expression of the FXR1 gene is not altered, and clearly does not compensate for the FMR1 functions that are lacking in these patients (1, 7) . Mice mutated for the Fxr2 gene show some phenotypic similarities to Fmr1 knockouts (KOs), suggesting that the functions of these genes overlap (8) , and double KOs further support this notion (D.L. Nelson, manuscript in preparation). In order to further understand the functional relationships among these genes, we sought to create a KO model for Fxr1.
One of the important functions assigned to FMRP is its ability to bind RNA. A number of studies have clearly demonstrated FMRP to interact with RNA in vivo to 4% of brain mRNA, including its own mRNA, and with structure specificity (9 -15) . Recombinant FMRP and FMRP immunoprecipitated from brain homogenates have revealed that a large proportion of FMRP-bound mRNAs harbours a purine (G) quartet structure (12, 16, 17) . FMRP binds to RNA as part of an mRNP complex (16) containing in addition to mRNA molecules, proteins including FXR1P, FXR2P, NuFip, Human Molecular Genetics, Vol. 13, No. 13 # Oxford University Press 2004; all rights reserved CYFIP, Nucleolin, YB-1 and staufen (15,18 -23) . Staufen is believed to be involved in transport of RNA granules in dendrites (24, 25) . In line with this finding, PC12 cells stably expressing a GFP -FMRP fusion protein have enabled the visualization of the trafficking of GFP -FMRP-containing granules into the neurites of these cells (26) . In addition to transport, FMRP has also been found to affect transcription, which was first demonstrated by its ability to non-specifically repress transcription in vitro in reticulocyte lysates and Xenopus oocytes (27, 28) and in co-transfection experiments (29) . More recently, translational modulation in vivo has been shown for elongation factor 1A mRNA (30) , type-1 metabotropic glutamate receptor (31) and modulation via the BC1 RNA (32) and phosphorylation (33) .
Relatively little is known currently about the functions of FXR1P and FXR2P, compared with FMRP. Fxr1p is expressed ubiquitously during early mouse embryogenesis, and primarily in the ganglia and neurons in the brain, the gonads and in skeletal and cardiac muscles towards the end of the gestation period (34) , in agreement with mRNA expression levels as determined by in situ hybridization (35) . FMRP is highly expressed in adult neurons and especially in Purkinje cells, where both FXR1P and FXR2P are also expressed in high levels. In testes FMRP, FXR1P and FXR2P are all expressed but at various levels and in different cell types (7) . In murine skeletal muscles, Fxr1p is expressed in high levels and is localized within the muscle contractile bands (36, 37) with only very weak signals visible for Fmrp and Fxr2p (36) . Fxr1 exhibits significant alternative splicing, and generates isoforms that vary from tissue to tissue (37) . In contrast, no alternative splicing has been reported for Fxr2, and the several isoforms produced by Fmr1 do not appear to be altered in relative abundance when comparing tissues (38, 39) .
Mice with loss-of-function mutations in Fmr1 and Fxr2 are currently available (8, 40) . These mouse strains are a valuable tool in the study of both genes (reviewed in 41) . No such model has been described for Fxr1. In our approach to study the function of FXR1P in vivo, we utilized embryonic stem cell technology to create a conditional knockout allele for Fxr1 by flanking the promoter and first exon of FXR1 with bacteriophage P1-derived lox P sites. Here we present data obtained from a detailed study of Fxr1 KO mice focused on pathology and biochemistry.
RESULTS

Generation of Fxr1 mouse lines
In the targeting construct, a 'floxed' neo cassette ( Fig. 1) was introduced into the first intron of Fxr1, to allow selection with G418 for the ES cells that had incorporated the construct by homologous recombination. After electroporation of the targeting plasmid into E14 ES cells, the DNA isolated from the 480 clones was subjected to PCR and Southern analyses yielding four homologous recombinants. Two clones (498 and 515) were used for further experiments. The neo cassette was removed in the ES cells by introduction of a plasmid expressing Cre-recombinase. ES clones that lost G418 resistance were isolated and tested for the presence of exon 1 flanked by lox P sites. Two different ES cell lines that still contained the neo cassette in intron 1 and two lines (clones 83 and 90) that lacked the neo cassette were injected into mouse blastocysts. Chimeric animals were crossed with C57BL/6 mice and the offspring tested for the presence of two or three lox P sites. Two independent mouse lines were created containing the neo cassette (Fxr1 þ neo) and two lacking the neo cassette but having a floxed exon 1 (Fxr1 conditional KO). Heterozygous Fxr1 KO mice were obtained through the mating of Fxr1 conditional KO mice with mice expressing Cre-recombinase under the control of the cytomegalovirus immediate early enhancer -chicken b-actin hybrid (CAG) promoter (T. de Wit and F. Grosveld, unpublished data). Maternally derived cre mRNA and protein have been found to be present in mature oocytes of CAG-cre mice ensuring a very early recombination of sequences flanked by lox P sites (42) .
Fxr1 1 neo mice
Homozygous Fxr1 þ neo neonates are indistinguishable at birth from their wild-type (WT) and heterozygous littermates, but their growth lags behind that of both WT and heterozygous pups, resulting in markedly smaller animals only a few days after birth. The mice continue to grow after birth, albeit at a slower rate than their WT littermates, and reach their maximum weight after 8 weeks (Fig. 2) . Thereafter, the condition of the Fxr1 þ neo mice slowly deteriorates resulting in a strikingly shortened life span averaging between 10 and 18 weeks.
Fxr1 KO mice
Fxr1 conditional KO mice do not appear to be different from WT mice. They were mated with CAG-Cre-expressing mice to obtain heterozygous Fxr1 KO offspring. Inbreeding of heterozygous Fxr1 KO mice produced homozygous Fxr1 KO pups. These pups are carried to term but die within a few hours after birth, confirming prior unpublished reports by Siomi et al. suggesting that Fxr1 KO leads to neonatal lethality. The litters obtained thus far exhibit no deviation from Mendelian expectations, suggesting all conceptions of homozygotes are viable. The size and weight of the KO pups at birth are not significantly different from either the heterozygous Fxr1 KO or the WT littermates.
Fxr1p distribution and western blotting
As a first screen for the absence of Fxr1p in cells from Fxr1 KO mice, we carried out immunocytochemical localization using monoclonal antibody 3FX on brain sections from both neonatal Fxr1 KO and adult Fxr1 þ neo mice (Fig. 3) . Fxr1p was highly expressed in cortical neurons from WT neonatal mice (Fig. 3A) , whereas Fxr1p was totally absent in cortical neurons from Fxr1 KO mice (Fig. 3B ). Fxr1p expression in cortical neurons from adult WT (Fig. 3C ) and adult Fxr1 þ neo (Fig. 3D ) mice showed a less obvious difference in level of expression; however, neurons from Fxr1 þ neo mice appear to stain less intensely for Fxr1p. Since immunocytochemical tests have a semi-quantitative character, and thus do not allow clear statements about exact levels of expression, the relative amounts of Fxr1p were determined quantitatively by detection on a western blot with rabbit antibody 830. Figure 4 shows the presence of reduced levels of the 82 and 84 kDa Fxr1p isoforms in the cardiac and skeletal muscles and smaller isoforms in brains of Fxr1 þ neo mice relative to the WT littermates. None of the Fxr1p isoforms visible in the WT extracts could be visualized in those derived from Fxr1 KO mice. These studies suggest that the Fxr1 KO mice do not produce significant levels of Fxr1p, while the Fxr1 þ neo mice have reduced levels along with possible alterations in the pattern of alternative splicing of the transcript. Fxr1 þ neo mice are likely hypomorphic mutants for Fxr1p. To control for differences in the amount of protein loaded onto the gel, the western blot was stripped and immunolabelled with antibody directed against proliferating cell nuclear antigen (PCNA). PCNA is a marker for cell cycle and is involved in DNA repair.
Macroscopic examination, pathology, immunohistochemistry and western analyses
To further detail the phenotypes observed in our mouse strains, the different organs from the mice were subjected to macroscopic examination. Analyses carried out on 6-weekold Fxr1 þ neo mice showed that their limb musculature is clearly less well-developed relative to WT offspring (Fig. 5A) . A number of organs such as the heart, lung, spleen and testes were reduced in size relative to the same organs in WT mice (data not shown). In Fxr1 KO neonates many of the internal organs including the heart, lung and brain appeared paler in colour than in WT neonates. In line with this observation, a number of large blood vessels visible under the skin and on the surfaces of several organs such as the brain in both WT and heterozygous KO neonates, are not clearly visible in KO neonates (Fig. 5B ). Hematocrit analysis carried out on blood samples from both WT and KO neonates showed no significant differences, indicating a normal red blood cell count. Importantly, the KO neonates also displayed limb musculature that is less well-developed than in the WT or heterozygous siblings, as described above for adult Fxr1 þ neo mice.
Since at the macroscopic level abnormalities in both Fxr1 þ neo and Fxr1 KO mice point to the limb musculature and cardiac tissue combined with the fact that Fxr1p is highly expressed in striated muscle tissue prompted us to focus on these tissues in greater detail. Microscopic analysis of haematoxylin and eosin (H&E) stained sections ( Fig. 6 ) from both skeletal muscle and cardiac tissues revealed a distinct difference in the general architecture of both tissues. In neonatal Fxr1 KO mice the muscle cells from the cardiac tissue ( Fig. 6B ) have a more transparent appearance and the total cytoplasmic volume appears reduced compared with cardiac tissue from WT littermates (Fig. 6A) . Also, in skeletal muscles the cytoplasm of muscle cells is reduced in the neonatal Fxr1 KO mice (Fig. 6D ) and more nuclei are seen compared with WT littermates (Fig. 6C ). Longitudinal sections from skeletal muscles from the adult Fxr1 þ neo mouse showed a significant reduction in the presence of the characteristic organization of the contractile filaments ( Fig. 6F ) compared with adult WT littermates (Fig. 6E) .
In the past, Fxr1p localization studies in striated muscle cells focused mainly on adult tissues; therefore, we started to study Fxr1p localization on neonatal skeletal muscle tissues using muscle-specific antibodies against Fxr1p. Figure 7A and B illustrates Fxr1p distribution in skeletal muscle tissue from WT and Fxr1 KO neonatal mice, respectively. Fxr1p is present in costameres in WT muscle cells from both skeletal muscles ( cytoskeleton, and this observation, combined with the observed pathology in Fxr1 þ neo mice with respect to changes in the characteristic organization of the contractile filaments, prompted us to focus further studies on the costameric protein network to unravel the cause of death of our Fxr1 KO mice.
Antibodies against costameric components a-actinin, vinculin, dystrophin and actin Skeletal muscles (limb) from both neonatal WT (Fig. 7C , G, K and O) and Fxr1 KO (Fig. 7D , H, L and P) were studied for these markers using specific antibodies. In addition, similar studies were performed for neonatal cardiac tissues from WT (Fig. 7E, I , M and O) and Fxr1 KO (Fig. 7F , J, N and R) mice. Alpha-actinin distribution (Fig. 7C -F) was significantly altered in both skeletal (compare Fig. 7C and D) and cardiac muscles (compare Fig. 7E and F) . However, the difference was more striking in cardiac muscles. For vinculin distribution (Fig. 7G -J ) the difference was less obvious; but also more prominent for cardiac muscles. Dystrophin distribution (Fig. 7K -N) was significantly reduced in skeletal muscles from Fxr1 KO mice compared with WT littermates (compare Fig. 7K and L) and even absent in cardiac muscles (compare Fig. 7M and N) . Finally, actin distribution ( Fig. 7O -R) was not dramatically altered in skeletal muscles from Fxr1 KO mice compared with WT littermates (compare Fig. 7O and P) , whereas for cardiac muscles, differences in distribution were more obvious (compare Fig. 7O and R) . A quantitative western was carried out on both WT and Fxr1 KO skeletal and cardiac muscles for a-actinin, vinculin and actin to determine whether there was a reduction in total cellular level of the respective proteins. Results shown in Figure 8 indicate no significant reduction in any of the three tested costameric proteins in the Fxr1 KO mice relative to the WT mice in both muscle types studied.
Hanging wire, grip and foot printing analyses
As a functional test for skeletal muscles, Fxr1 þ neo mice and WT littermates were subjected to a number of simple muscle strength/coordination tests. During the 'hanging wire' experiments Fxr1 þ neo mice were unable to grasp the metal wire with sufficient strength to support their own body weight and let go immediately whereas their WT and heterozygous littermates could hang on to the horizontal wire for extended periods of time (data not shown). The grip test corroborated the data obtained from the hanging wire experiments showing that the combined strength of the four limbs of the Fxr1 þ neo mice was severely reduced (data not shown). Data obtained from the walking track analyses show an altered foot print pattern produced by the Fxr1 þ neo mice compared with WT littermates (Fig. 9 ). Relative to their littermates, Fxr1 þ neo mice not only have a shorter stride length, they also display signs of gait abnormalities.
DISCUSSION
Knowledge about the function of FXR1P in vivo remains limited. To begin to tackle this shortfall we set out to generate an animal model that would enable us to study the effect of the absence of Fxr1p in mice. An Fxr1 conditional KO mouse line harbouring a floxed promoter and first exon of Fxr1 was obtained. Crosses between heterozygous Fxr1 KO mice resulted in 25% Fxr1 KO neonates that died within a few hours after birth. Immunocytochemistry in addition to western analyses carried out on brain, skeletal and cardiac muscle tissues obtained from these mice show a total absence of detectable Fxr1p (Figs 3 and 4) .
In addition to the Fxr1 KO mouse, a second mouse model was generated, the Fxr1 þ neo strain, in which a floxed anti-sense neomycin cassette was inserted just downstream of the first exon, in intron 1 of Fxr1. Interestingly homozygous Fxr1 þ neo pups obtained from crosses between heterozygous Fxr1 þ neo mice did not display neonatal lethality and were found to express Fxr1p (Figs 3 and 4) but at a strongly reduced level compared with that seen in WT littermates. These data indicate that the presence of Fxr1p is essential for normal embryogenesis and birth to occur and that apparently even very small levels are enough to overcome the lethality observed in Fxr1 KO animals just after birth. An explanation for why the neomycin induced a hypomorphic phenotype could lie in the negative stearic hindering effect exerted by the high level of transcription from the PGK promoter driving the neomycin cassette relative to the endogenous Fxr1 promoter oriented in the opposite direction. Northern analysis showed the presence of Fxr1 transcripts of the expected lengths in 6-week-old WT mice; but it was undetectable in RNA isolates from Fxr1 þ neo littermates (data not shown). Examples of neo cassette-induced interference have been described earlier (43) . Another possibility may be the low abundance of correctly spliced messenger RNAs due to cryptic splice acceptor/donor sites present in the neomycin cassette. However, the presence of aberrantly spliced mRNA was investigated but not found (data not shown). The Fxr1 þ neo mouse does, however, offer the ability to study the role of Fxr1p during embryogenesis and beyond, which would otherwise not be possible in the full Fxr1 KO.
Macroscopically, Fxr1 KO neonates and their WT littermates do not differ much from each other, with the exception of a lack of large blood vessels otherwise clearly visible on the surface of the brain and other tissues in WT mice (Fig. 5B) and a paler appearance of organs such as the heart, lung and brain. Closer microscopic examination of various tissue sections did not point to a gross reduction in the number of blood vessels (data not shown). Also no differences were found in the red blood cell count between the WT and KO neonates (data not shown). Fxr1 þ neo pups, on the other hand, displayed a severely reduced limb musculature only a few days after birth in addition to weight loss (Fig. 5A) . The fact that a muscle phenotype is observed as a result of very low expression of Fxr1p in a tissue where it is normally highly expressed in WT mice made the striated muscles an obvious candidate for a more closer study. We also determined the extent to which the macroscopic alterations in both the cardiac and skeletal muscles could be seen at the microscopic level. By means of a general H&E stain, Fxr1 KO E19 cardiac sections showed a clear loss of architectural structure that is otherwise present in WT samples. Such disarray was not that obvious in skeletal muscle samples obtained from Fxr1 KO embryos that displayed thinner muscle fibres with an increase in the number of nuclei relative to WT-derived material. Using immunocytochemistry, Fxr1p was found to localize along the Z-lines and costameres in a punctated pattern in WT muscle sections as was previously also suggested by Dube et al. (37) .
Costameres are periodically placed sites along the sarcolemma that connect the extracellular matrix to the Z-disks in the muscle (reviewed in 44). The dystrophin/glycoprotein Figure 8 . Western blot analysis carried out on cardiac and skeletal muscles from WT and Fxr1 KO E19 embryos. Antibodies against a-actinin, vinculin and actin were used. PCNA staining served as a loading control. complex (DGC) together with the integrin receptor complex anchored in the sarcolemma, link the extracellular basal lamina via costameric proteins including gamma-actin, talin, vinculin, alpha-actinin, desmin and vimentin to the Z-disk. Together, these proteins form a structure that is believed to serve the function of transferring the force generated by myofibrils during muscle contraction to the sarcolemma and subsequently to the extracellular matrix (45 -48) . In addition, costameres have been suggested to play a role in converting mechanical stimuli to alterations in cell signalling or gene expression. In the current study, experiments with antibodies directed against costameric proteins a-actinin, vinculin, dystrophin and actin in WT muscle sections showed that the costameric architecture was altered and suggests a function for Fxr1p in normal costamere architecture. Very intriguing was the finding that E19 Fxr1 KO skeletal and cardiac muscles displayed a loss of the typical striated banding pattern seen for a-actinin and vinculin and a strong reduction in the intensity of the dystrophin signal normally seen on the sarcolemma of myofibrils. Western analysis using antibodies directed against a-actinin, vinculin and actin did not show a significant difference between WT and Fxr1 KO in the total cellular level of a-actinin, vinculin and actin in both striated and cardiac muscles. This would suggest that the costameric proteins are delocalized and that transcription and expression may not be affected.
Dystrophin is a large membrane-associated protein found in muscle and brain cells and is located on the inner face of the cell membrane together with sarcoglycan and dystroglycan to form the DGC (reviewed in 49). Mutations in the dystrophin gene lead to Duchenne muscular dystrophy (DMD), which manifests as a severe wasting of skeletal muscle resulting in premature death usually due to cardiomyopathy. A mouse model for this disease, the mdx mouse, lacks any discernable dystrophin protein due to a single point mutation resulting in a truncated protein (50, 51) . Mdx mice rarely display cardiac abnormalities often encountered in human DMD patients but do suffer from dystrophic changes in heavily Figure 9 . Foot print analysis carried out on WT and Fxr1 þ neo mice. The front paws of each mouse were smeared with white non-toxic paint and the hind paws with orange paint.
used muscles such as the diaphragm (52) . Double KO mice for both dystrophin and its homologue utrophin also do not develop the strong cardiomyopathy seen in human DMD patients but they do exhibit a shortened lifespan of 15 weeks (53, 54) . In light of these findings it is unlikely that the Fxr1 KO lethality is due to the loss in dystrophin expression. Vinculin is a 117 kDa protein that acts as a bridge between the extracellular matrix, binding talin at its amino-terminal end and the actin cytoskeleton (55) . With the aid of a mouse vinculin KO model, vinculin deficiency has been found to result in an embryonic lethal phenotype attributed to severe heart and brain defects, leading to the reabsorption of the embryos between days E8 and E10 of gestation (56). Although we cannot, with absolute certainty, ascribe the cause of the Fxr1 KO neonatal lethality to the loss of cellular architecture and/or tissue organization, the severe phenotype manifested in the vinculin KO mouse makes it plausible that the severe loss of the normal striated expression pattern for vinculin seen in Fxr1 KO neonates may contribute to their lethality. This, further compounded with the delocalization of dystrophin and a-actinin, in addition to other as yet untested structural proteins, is likely to result in either cardiac or respiratory failure within the first few hours of life. On the other hand, a general delay in muscle development with consequent late occurrence of the characteristic striated appearance as a result of unknown cause cannot be excluded.
Costameric proteins vinculin and vimentin are normally found at the costameres and Z-disks in skeletal muscles. In situ hybridizations carried out with specific probes directed against vinculin and vimentin mRNA reveal a co-localization of the messenger and the protein (57, 58) . This indicates the existence of a specific mechanism for translational control of mRNA at the costameres. Interestingly, Raver1, a protein that contains RNA-binding motifs, has been shown to co-localize and bind vinculin and a-actinin mRNA in costameres of skeletal muscles. Raver 1 has been hypothesized to play a role in translational regulation of vinculin and a-actinin (59). FXR1P interacts with CYFIP2 (19), which was found (in turn) to be a component of the WAVE1 complex, which is involved in actin polymerization (60). The question that remains then is how the lack of Fxr1p results in the misdirected expression of proteins dystrophin, vinculin and a-actinin? The answer may be found in the structural similarities that FXR1P shares with its paralogue FMRP. In neurons FMRP is known to bind to specific target mRNAs and as part of an mRNP complex transport these mRNA molecules to the neurites where RNP particles are believed to be docked at this particular site using the F-actin cytoskeleton followed by translation upon specific stimuli (26, 32) . FXR1P also has been shown to bind RNA and although its preference for specific mRNA is yet to be determined, it has been found to be one of the components of the mRNP complex (26) . Even in the absence of Fmrp, Fxr1p is still able to associate with the mRNP complex (data not shown). Since FXR1P is the only fragile X protein family member significantly present in muscle cells, and based on the data presented here, we would like to propose that FXR1P fulfils an analogous function in muscle cells as that seen for FMRP in neurons, and that FXR1P may be responsible for the transport of dystrophin, vinculin, a-actinin and other structural costameric mRNAs from the nucleus to the costameric protein network of the muscle cells and may even play a role in local translational control. Proof for this will come from future experiments that identify the mRNA species that FXR1P interacts with and determine whether FXR1P influences their translation. An alternative explanation for the altered protein distribution found, which at present cannot be ruled out, may be the consequence of unhealthy or dying muscle tissue. This will also be looked into in future experiments.
The generation of a conditional Fxr1 KO mouse line has left open a number of avenues that are yet to be explored. In the brain of Fxr1 KO neonates, no effects at the macroscopic level could be detected. Owing to the neonatal lethality, the effects of Fxr1p deficiency during brain development could not be studied as this involves behavioural tests. The use of (inducible) brain-specific Cre-recombinase-expressing mouse strains will enable the generation of mice that are lacking Fxr1p only in the brain and will thus likely be viable. Similarly, the use of inducible muscle-specific Cre expressers will enable one to study the effects of Fxr1p in muscle tissues in a temporal fashion during embryogenesis or thereafter. Limiting expression to the testis is another possibility employing a testis-specific Cre expresser. With the availability of mouse KO models for the other two paralogues Fmr1 and Fxr2, the role of each gene can now be studied separately with crosses to obtain the various double KO strains and ultimately the (inducible) triple KOs. These studies should allow the opportunity to determine the role of the Fxr1 and Fxr2 genes in compensating for the loss of Fmr1, and help to fully delineate the function(s) of Fmr1. Another mouse strain that is currently being set up in our laboratory is very similar to the Fxr1 þ neo mouse with the exception of the absence of one of the lox P sites situated upstream of the Fxr1 promoter. Upon crossing the new mouse strain with an appropriate Cre expresser, Fxr1p expression will increase from that seen in the Fxr1 þ neo mice to WT levels, in essence enabling the ability to rescue the hypomorphic phenotype.
The repercussions of the work presented here on the human population, upon extrapolation of our findings in mice to humans, are yet to be determined. The prevalence of naturally occurring FXR1 mutations in the human population as well as in children born with muscle abnormalities is unknown. The screening of tissue samples for FXR1P expression from babies with a muscle phenotype of unknown aetiology will improve their diagnosis and with further research hopefully their prognosis.
MATERIALS AND METHODS
Construction of Fxr1 targeting construct
Subcloned fragments (6-30, 6-31 and 6-26) from PAC clone RPCI-21 316J6 were used to create the targeting vector pFxr1-cre/lox KO78 (37) . Briefly, a phosphoglycerate kinase (PGK) promoter-driven neomycin resistance gene (neo ) flanked by lox P sites was inserted into an Xba I site in the first intron of Fxr1 in the transcriptional orientation opposite that of Fxr1. A third lox P site was placed into an Xba I site 800 bp upstream of exon 1, introducing a Not I site. The targeting vector provided 3.1 kb of homology with the locus upstream of the 5 0 lox P site, and 3.4 kb of homology 3 0 to the floxed neo cassette in intron 1.
Homologous recombination in ES cells
The targeting construct pFxr1-cre/lox KO78 was linearized with Sal I to facilitate homologous recombination of the plasmid with the ES cell genome. Electroporation was performed using 10 7 E14 ES cells in 400 ml phosphate-buffered saline (PBS) with a Progenetor II Gene Pulser (1200 mF and 117 V for 10 ms). Selection of transfectants was performed by selecting for the presence of the neo cassette with G418 (200 mg/ml). After cells were cultured to promote colony formation, individual colonies were picked and cultured. From each clonal colony, half was frozen and half was used for DNA isolation to identify homologous recombination events. Of the 480 clones picked after electroporation of ES cells with the targeting construct, 192 were likely homologous recombinants, as they were found not to produce a PCR product with ampicillin-specific primers (AmpF: CAACA TTTCCGTGTCGCCCT; AmpR: TCCCAACGATCAAGG CGAGT). By PCR analysis 44 clones were found to harbour the 5 0 lox P site (Lox1F: GATAGTGCTGTGTGTAGCTCCG; Lox1R: GCTCCTGGCCCCTAGCAAC). Of these clones, four showed the expected banding pattern in Southern blot analyses with both the 5 0 (350 bp PCR product on p6-33 with primers: CTGGTTGCTCCAAGATGAG and CTCAA-CACTAACTAGTGTGGC) and 3 0 probes (320 bp PCR product from p6-34 GTCTGAAGTTAATAATTAAAAC-CAGTCATCG and GGGGAGGGAAGCAGCCAATCATG). Clones 498 and 515 were chosen after karyotyping and injected into C57BL/6J blastocysts that were implanted in pseudo-pregnant BCBA females.
In vitro Cre expression
Clones 498 and 515 were each electroporated with pMC-Cre, a plasmid for transient Cre expression, to excise the neomycin cassette creating the conditional KO allele. Again, individual clones were picked, DNA isolated and subjected to both PCR and Southern analysis to determine the conditional KO allele-carrying clone. Resulting ES cell clones 83 and 90 were chosen after karyotype analysis and used for blastocyst injections.
DNA analysis
DNA was obtained from ES cells or mouse tails by incubating with Proteinase K (Sigma) in 335 ml lysis buffer [10 mM TrisHCl, 400 mM NaCl, 2 mM EDTA, pH 7.3 -7.4, 1% sodium dodecyl sulphate (SDS)] overnight at 558C. An aliquot of 100 ml 6 M NaCl was added, and the suspension centrifuged. DNA was precipitated with 1 ml 96% ethanol and washed in 70% ethanol. DNA was dissolved in 100 ml H 2 O. Southern blot analysis was performed on all isolated ES cell clones that were initially screened by PCR to identify homologous recombination events.
Western analyses
Tissues were each homogenized in lysis buffer [10 mM HEPES, 300 mM KCl, 5 mM MgCl 2 , 5 mM CaCl 2 , 0.45% Trition X-100, 0.05% Tween, pH 7.6; protease inhibitor cocktail mix (Roche)]. Homogenates were spun down, and 200 mg protein from each sample was boiled in SDS-loading buffer and run on a 7.5% SDS-polyacrylamide gel and electroblotted onto nitrocellulose. Fxr1p was detected using a rabbit antibody 830 (1 : 5000) (39) as the primary antibody. a-Actinin (Chemicon), vinculin (Sigma), dystrophin (Dys1; Novocastra), actin (AC40; Sigma) and PCNA antibodies were used to detect the respective proteins in quantitative western analyses. Horseradish peroxidase (HRP)-labelled anti-mouse IgG was used as secondary antibody, allowing chemiluminescence detection with ECL (Amersham).
Pathology
The weight of each embryo or neonate was determined in addition to the weight of the individual organs isolated thereafter. In addition, E18 embryos, neonates or 6-week-old mice were fixed in 3% paraformaldehyde. For embryos and neonates whole body fixation was performed for 1 day followed by dissection of the different organs. For microscopic analysis we focused on brain, cardiac and skeletal muscle tissues. For adult mice (6 weeks old), the different organs were first dissected before fixation (1 day). Subsequently, organs were processed for paraffin embedding according to standard protocols. Paraffin sections (5 mm) were stained for routine microscopic analysis using the standard H&E staining protocol. Finally, sections were examined using a Zeiss axioskop at magnification 100Â.
Immunocytochemistry
Fxr1p localization in paraffin embedded brain sections from WT, Fxr1 KO and Fxr1 þ neo was studied using monoclonal antibody 3FX (39) in an indirect immunoperoxidase method (39) . Similar localization studies were performed on paraffin sections from WT and Fxr1 KO striated muscle tissue (both skeletal muscle and cardiac tissues) using musclespecific rabbit antibodies against Fxr1p (37, 39) . To further characterize abnormalities in the architecture of both skeletal muscle and cardiac tissues, the immunocytochemical distribution of several well-characterized cytoskeletal proteins was studied, with special emphasis to proteins of the costameric network, including a-actinin (Chemicon), vinculin (Sigma), dystrophin (Dys1; Novocastra) and actin (AC40; Sigma). For all immunocytochemical tests either anti-rabbit or anti-mouse Igs conjugated with HRP were used as secondary step. Microwave treatment was performed for antigen retrieval (36) . Antigen -antibody complexes were visualized by incubation in a substrate solution, containing hydrogen peroxide and DAB followed by counterstaining with haematoxylin. Endogenous peroxidase activity was inhibited by a 30 min incubation in PBS -hydrogen peroxide -sodium azide solution prior to incubation with specific antibodies. The specificity of the labelling procedure was tested by omitting the primary antibody substitution of the primary antibody with normal rabbit or mouse serum or using tissues from Fxr1 KO mice (only for Fxr1p distribution). Background staining in these control sections was negligible. Notably, monoclonal antibody 3FX has been reported to cross-react with Fxr2p as well; however, using our conditions for paraffin sections no signal could be detected in brain tissue from the Fxr1p KO mouse, indicating absence of cross-reactivity with Fxr2p.
Hanging wire, grip tests and walking track analyses Hanging wire. Mice were allowed to grasp a horizontal wire, after which the wire was elevated 30 cm, and the length of time that the mouse was able to maintain a grip on the wire was recorded.
Grip test. Mice were held by their tails and were allowed to grip a horizontal metal grid (Bioseb) with all paws. The mouse was slowly moved in the horizontal plane away from the apparatus until it released its grip. The maximum force exerted was recorded.
Walking track. Foot prints were recorded in a well-lit walking alley with a darkened goal box at the end (61) . The anatomical landmarks on the front and hind feet of the mice were smeared with finger paint. The mice were allowed to walk down the track, leaving foot prints on normal paper. Multiple recordings were made for each mouse.
